Merck Chairman and CEO Kenneth Frazier runs a massive operation that grossed $44 billion in 2013 and has developed prescription drugs, vaccines, therapies and health products that treat individuals in more than 140 countries. It is the nation’s third biggest drug manufacturer with 76,000 employees across the globe and another 1,300 through joint ventures in China and Brazil as well as spends a whopping $7.5 billion in R&D to find treatments for cancer, diabetes and hepatitis, among other ailments.